Year: 2025
Type: article
Abstract: ABSTRACT In addition to exhibiting significant cytotoxic capabilities, γδ T cells play a crucial role as a bridge between innate and adaptive immunity. Although γδ T cells have been demonstrated to orchestrate interactions with other immune cells, their impact on αβ T cells in the setting of acute myeloid leukemia (AML) remains unexplored. In this study, we found that functional deficiencies of αβ T cells were significantly associated with the downregulation of HLA‐DR + γδ T cells in patients newly diagnosed with AML. Vδ2 + T cells, which constitute a predominant subset of γδ T cells in human peripheral blood, exhibited elevated levels of HLA‐DR following ex vivo expansion. Notably, a lower dose of the expanded Vδ2 + T cells did not induce direct cytotoxicity against AML cells; instead, they significantly enhanced the cytotoxic capacity of primary αβ T cells toward AML cells. Furthermore, blockade of HLA‐DR on Vδ2 + T cells markedly diminished this facilitating effect. Taken together, our findings demonstrate an important indirect role for Vδ2 + T cells beyond their direct killing ability in the context of anti‐AML immunity and provide novel insights into the therapeutic potential of adoptive Vδ2 + T cell therapy.
Source: European Journal of Immunology
DOI: 10.1002/eji.70025
Authors: Keli Yue, Shuang Liang, Ning Wu, Mingzhu Jia, Haitao Gao, Cong Cheng, Lijuan Hu, Jiangying Liu
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Award: G6332574528
OpenAlex ID: W4413050273
